CGEN 6-K files Q3 2025 results; press release tied to F-3
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Compugen Ltd. (CGEN) filed a Form 6-K stating it furnished a press release with the company’s third quarter 2025 results as Exhibit 99.1. The filing notes that, with the exception of quotes attributed to Eran Ophir, Ph.D., the press release is incorporated by reference into the company’s effective Form F-3 registration statement (File No. 333-270985).
The report was signed by Eran Ben Dor, General Counsel, on November 10, 2025. Investors seeking financial details should refer to Exhibit 99.1, which contains the full Q3 2025 results.
Positive
- None.
Negative
- None.
FAQ
What did Compugen (CGEN) file?
A Form 6-K furnishing a press release containing the company’s Q3 2025 results as Exhibit 99.1.
Is the press release part of Compugen’s shelf registration?
Yes. Except for quotes by Eran Ophir, Ph.D., it is incorporated by reference into Form F-3 File No. 333-270985.
Where can I find the Q3 2025 financial details for CGEN?
In Exhibit 99.1 to the Form 6-K, which contains the full Q3 2025 results press release.
Who signed the Form 6-K for Compugen?
Eran Ben Dor, General Counsel.
When was the Form 6-K dated?
November 10, 2025.
What content is excluded from incorporation by reference?
Quotes attributed to Eran Ophir, Ph.D., are excluded from incorporation into the Form F-3.